IL139144A0 - Mycobacterial inhibitors - Google Patents

Mycobacterial inhibitors

Info

Publication number
IL139144A0
IL139144A0 IL13914499A IL13914499A IL139144A0 IL 139144 A0 IL139144 A0 IL 139144A0 IL 13914499 A IL13914499 A IL 13914499A IL 13914499 A IL13914499 A IL 13914499A IL 139144 A0 IL139144 A0 IL 139144A0
Authority
IL
Israel
Prior art keywords
mycobacterial
mycobacterial inhibitors
inhibitors
treatment
certain
Prior art date
Application number
IL13914499A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9802118A external-priority patent/SE9802118D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL139144A0 publication Critical patent/IL139144A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
IL13914499A 1998-05-05 1999-05-03 Mycobacterial inhibitors IL139144A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN969MA1998 1998-05-05
SE9802118A SE9802118D0 (sv) 1998-06-15 1998-06-15 Mycobacterial inhibitors
PCT/SE1999/000732 WO1999065483A1 (fr) 1998-05-05 1999-05-03 Inhibiteurs mycobacteriens

Publications (1)

Publication Number Publication Date
IL139144A0 true IL139144A0 (en) 2001-11-25

Family

ID=26324850

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13914499A IL139144A0 (en) 1998-05-05 1999-05-03 Mycobacterial inhibitors

Country Status (14)

Country Link
US (1) US6476053B1 (fr)
EP (1) EP1075261B1 (fr)
JP (1) JP2002518324A (fr)
KR (1) KR20010043322A (fr)
CN (1) CN1201735C (fr)
AT (1) ATE322898T1 (fr)
AU (1) AU739140B2 (fr)
BR (1) BR9910185A (fr)
CA (1) CA2330667A1 (fr)
DE (1) DE69930844T2 (fr)
IL (1) IL139144A0 (fr)
NO (1) NO20005548L (fr)
NZ (1) NZ507620A (fr)
WO (1) WO1999065483A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002350115A1 (en) 2001-11-01 2003-05-12 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
JP2009504719A (ja) * 2005-08-19 2009-02-05 アストラゼネカ アクチボラグ 結核症の治療のためのピラゾロン誘導体
GB0520368D0 (en) * 2005-10-06 2005-11-16 Univ Aston Antibacterial pyrrols
WO2010063617A1 (fr) * 2008-12-04 2010-06-10 Basf Se Mélanges d'acide itaconique ou de dérivés d'acide itaconique et d'amines primaires pour la production de 1,3- et de 1,4-alkylméthylpyrrolidones
JP7046812B2 (ja) * 2015-12-23 2022-04-04 ヘンケル・アクチェンゲゼルシャフト・ウント・コムパニー・コマンディットゲゼルシャフト・アウフ・アクチェン 金属加工液
CN107033060B (zh) * 2017-05-04 2020-01-14 浙江工业大学 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用
US11890364B2 (en) 2017-12-01 2024-02-06 Good T Cells, Inc. Composition for prevention or treatment of hair loss

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883342A (en) * 1973-04-13 1975-05-13 Akzona Inc Plant growth regulators

Also Published As

Publication number Publication date
AU4304199A (en) 2000-01-05
EP1075261A1 (fr) 2001-02-14
EP1075261B1 (fr) 2006-04-12
WO1999065483A1 (fr) 1999-12-23
BR9910185A (pt) 2001-01-09
JP2002518324A (ja) 2002-06-25
CN1308532A (zh) 2001-08-15
NO20005548D0 (no) 2000-11-03
US6476053B1 (en) 2002-11-05
KR20010043322A (ko) 2001-05-25
NZ507620A (en) 2003-05-30
CN1201735C (zh) 2005-05-18
DE69930844D1 (de) 2006-05-24
CA2330667A1 (fr) 1999-12-23
NO20005548L (no) 2000-12-04
DE69930844T2 (de) 2006-12-28
AU739140B2 (en) 2001-10-04
ATE322898T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
DE69905170D1 (en) Thiazolopyrimidinderivate
AP9901514A0 (en) Pyrazolopyrimidinone cgmp PDE5 inhibitors for the treatment of sexual disfunction
YU15299A (sh) Farmaceutski sastavi
WO2001044247A3 (fr) Agents et methodes de traitement des maladies hyperplasiques
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
BG105270A (en) Tetrahydropyridoethers
HK1051499A1 (en) Method for treating ocular pain
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
EP1171428A4 (fr) Inhibiteurs de fab i
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
SE9802937D0 (sv) Novel compounds
MXPA01010403A (es) Agentes quimiotacticos e inhibidores derivados de osteopontina y usos de los mismos.
GB9804886D0 (en) Therapeutic combination
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
GB9907571D0 (en) Compounds
IL139144A0 (en) Mycobacterial inhibitors
HK1043058A1 (zh) 異環磷酰胺芥子類似物及其用途
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
GB9626472D0 (en) New use of comt inhibitors
PT1042288E (pt) Inibidores de tripeptidil peptidase
AU5434899A (en) Cancer treatment
MXPA03010451A (es) Nuevos metodos para el tratamiento y prevencion del dolor.